ACADIAN ASSET MANAGEMENT LLC - KINIKSA PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$3,919
+1164.2%
226,181
+916.6%
0.02%
+1500.0%
Q2 2023$310
+69.4%
22,248
+29.7%
0.00%0.0%
Q1 2023$183
-5.2%
17,159
+31.9%
0.00%0.0%
Q4 2022$193
-99.9%
13,014
-7.2%
0.00%
-50.0%
Q2 2020$357,000
+305.7%
14,021
+146.2%
0.00%
+100.0%
Q1 2020$88,0005,6950.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 600,000$8,988,0001.31%
Rubric Capital Management LP 1,569,503$23,511,1551.02%
SPHERA FUNDS MANAGEMENT LTD. 307,283$4,603,0990.99%
HHLR ADVISORS, LTD. 2,623,924$39,306,3820.83%
Parkman Healthcare Partners LLC 191,307$2,865,7790.76%
AlphaCentric Advisors LLC 45,000$674,1000.67%
RICE HALL JAMES & ASSOCIATES, LLC 697,162$10,443,4870.60%
Lion Point Capital, LP 346,500$3,689,0000.52%
EAM Global Investors LLC 116,864$1,750,6230.45%
Jackson Creek Investment Advisors LLC 61,609$9230.41%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders